HUMA

HUMA

USD

Humacyte Inc. Common Stock

$1.330+0.030 (2.308%)

实时价格

Healthcare
生物技术
美国

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$1.300

最高价

$1.340

最低价

$1.220

成交量

3.25M

公司基本面

市值

249.1M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

5.40M

交易所

NMS

货币

USD

52周价格范围

最低价 $1.15当前价 $1.330最高价 $6.77

相关新闻

Analyst Upgrades

BTIG Maintains Buy on Humacyte, Lowers Price Target to $6

BTIG analyst Ryan Zimmerman maintains Humacyte with a Buy and lowers the price target from $7 to $6.

查看更多
BTIG Maintains Buy on Humacyte, Lowers Price Target to $6
GlobeNewswire

Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering

DURHAM, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today

查看更多
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering
Analyst Upgrades

D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target

D. Boral Capital analyst Jason Kolbert maintains Humacyte with a Buy and maintains $25 price target.

查看更多
D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target
GlobeNewswire

Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus

– Patent covers esophagus produced using Humacyte's proprietary bioengineered regenerative tissue platform, designed for implant in patients with damaged esophagus –

查看更多
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus